title: Traditional and novel aspects of the metabolic actions of growth hormone.
abstract: Growth hormone has been known to be diabetogenic for almost a century and it's diabetogenic properties fostered consideration of excessive and abnormal GH secretion as a cause of diabetes, as well as a role in the microvascular complications, especially retinopathy. However, besides inducing insulin resistance, GH also is lipolytic and a major anabolic hormone for nitrogen retention and protein synthesis. These actions are best illustrated at the extremes of GH secretion: Gigantism/acromegaly is characterized by excessive growth, CHO intolerance, hyperplasia of bone, little body fat and prominent muscle development, whereas total deficiency of GH secretion or action is associated with adiposity, poor growth, and poor muscle development. These actions also become apparent during puberty and pregnancy, times when GH secretion is increased and account for the characteristic changes in body composition and tendency to diabetes. More recently, tissue specific deletions of the GH receptor (GHR), have uncovered newer metabolic effects including it's essential role in triglyceride export from the liver when GHR is deleted in the liver, leading to hepatic steatosis and ultimately to hepatic adenoma formation, effects which may explain these findings in obesity, a state of diminished GH secretion and action. In addition deletion of GH action in muscle and fat is associated with specific patterns of disturbed phenotype and metabolic effects in CHO, fat, and protein metabolism affecting the specific tissue and whole body function. This chapter provides an overview of these classic and newer metabolic functions of GH, placing this hormone and its actions in a central role of body fuel economy in health and disease.
authors.affiliation: Department of Pediatrics, Division of Endocrinology, Diabetes and Metabolism, Children's Hospital, University of Pittsburgh School of Medicine, United States.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Sperling
mesh_terms: D050260:Carbohydrate Metabolism; D003920:Diabetes Mellitus / Q000378:metabolism*; D019382:Human Growth Hormone / Q000378:metabolism*; D006801:Humans; D007333:Insulin Resistance; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism; D009765:Obesity / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D011627:Puberty / Q000378:metabolism*; D014280:Triglycerides / Q000378:metabolism
chemical_list: D011506:Proteins; D014280:Triglycerides; D019382:Human Growth Hormone
keywords: Carbohydrate; Fat; Growth hormone; Growth hormone receptors; Metabolism; Protein